Education
About Us
Working with TipRanks
Follow Us
Lori Freedman Insider Profile
4 Followers
Lori Freedman, VP Corp. Affairs, GC and Sec at EyePoint Pharmaceuticals, holds 846.46K shares in Organogenesis Holdings (Ticker: ORGO), holds 96.42K shares in EyePoint Pharmaceuticals (Ticker: EYPT). Most recently, Lori Freedman Bought ― shares of Organogenesis Holdings on Jun 06, 2025 for an estimated value of 724.22K.
Lori Freedman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lori Freedman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lori Freedman
Lori Freedman's Trading History
EyePoint Pharmaceuticals
Jun 18, 2014
VP Corp. Affairs, GC and Sec
Uninformative Sell
31.63K
$1.01M
Organogenesis Holdings
Jun 06, 2025
Chief Admin. and Legal Officer
Informative Buy
724.22K
$4.02M
List of latest transactions for each holding click on a transaction to see Lori Freedman's performance on stock
You May Also Like
Lori Freedman insider profile FAQ
What is the percentage of profitable transactions made by Lori Freedman?
The percentage of profitable transactions made by Lori Freedman is ―.
What is the average return per transaction made by Lori Freedman?
The average return per transaction made by Lori Freedman is ―.
What stocks does Lori Freedman hold?
Lori Freedman holds: EYPT, ORGO stocks.
What was Lori Freedman’s latest transaction?
Lori Freedman latest transaction was an Informative Buy of $724.22K.
What was Lori Freedman's most profitable transaction?
Lori Freedman’s most profitable transaction was an Informative Buy of ORGO stock on June 6, 2025. The return on the trade was 44.20%.
What is Lori Freedman's role in EyePoint Pharmaceuticals?
Lori Freedman's role in EyePoint Pharmaceuticals is VP Corp. Affairs, GC and Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.